Leukemia and rosiglitazone

Leukemia and rosiglitazone

Bibliographic Details
Main Authors:	Irfan Yavasoglu, Gurhan Kadikoylu, Zahit Bolaman
Format:	Article
Language:	English
Published:	Elsevier 2016-03-01
Series:	Saudi Pharmaceutical Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016415000808

Similar Items

Multiple Myeloma and Alkaline Phosphatase
by: İrfan Yavaşoğlu, et al.
Published: (2015-05-01)

Inclusion Body in a Leukocyte in Crimean-Congo Hemorrhagic Fever
by: Zahit Bolaman, et al.
Published: (2015-07-01)

Penile ulcer ATRA related in patient with acute promyelocytic leukemia
by: Irfan Yavasoglu, et al.
Published: (2012-08-01)

Penile ulcer ATRA related in patient with acute promyelocytic leukemia
by: Irfan Yavasoglu, et al.
Published: (2012-01-01)

Chronic lymphocytic leukemia and JAK2 V617F positive essential thrombocythemia: Distinct clonal diseases?
by: Deniz Çetin, et al.
Published: (2014-08-01)

Bone and Bone Marrow Involvement in Sarcoidosis
by: Gökhan Sargın, et al.
Published: (2014-05-01)

Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases
by: Mert Küçük, et al.
Published: (2012-08-01)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
by: Mert Küçük, et al.
Published: (2013-09-01)

Serum Bcl-2 Levels in Patients with β-Thalassemia Minor: A Pilot Study
by: İrfan Yavaşoğlu, et al.
Published: (2014-12-01)

Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment
by: Zahit Bolaman, et al.
Published: (2012-01-01)

Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma
by: Irfan Yavasoglu, et al.
Published: (2015-02-01)

BONE MARROW INVOLVEMENT IN A PATIENT WITH ALPHA HEAVYCHAIN DISEASE:RESPONSE TO TETRACYCLINE TREATMENT
by: Zahit Bolaman, et al.
Published: (2014-08-01)

LUNG CLEAR “SUGAR” CELL TUMOR AND JAK V617F POSITIVE ESSENTIAL THROMBOCYTHEMIA: COINCIDENCE
by: Volkan Yazak, et al.
Published: (2014-08-01)

Sweet Syndrome Associated with Ixazomib
by: İrfan Yavaşoğlu, et al.
Published: (2021-08-01)

Auer Rods Are Not Seen in Non-Neoplastic Cells
by: İrfan Yavaşoğlu, et al.
Published: (2016-11-01)

Disseminated Scabies During Induction Chemotherapy for Acute Promyelocytic Leukemia
by: Ali Zahit Bolaman, et al.
Published: (2023-06-01)

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms
by: Neslihan Andıç, et al.
Published: (2016-08-01)

The Development of Transfusion-Related Acute Lung Injury for the Second Time: A New Awareness for Daratumumab?
by: Atakan Turgutkaya, et al.
Published: (2021-09-01)

Experience of Daratumumab in Six Patients With Multiple Myeloma and Kidney Failure
by: Atakan Turgutkaya, et al.
Published: (2021-09-01)

Bortezomib-Based Regimens and Plasma Cell Leukemia
by: Ali Zahit Bolaman
Published: (2021-02-01)

The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome
by: Atakan Turgutkaya, et al.
Published: (2022-07-01)

Masquerading of COVID-19 Infection as Primary Mediastinal Large B-Cell Lymphoma
by: Ali Zahit Bolaman, et al.
Published: (2021-02-01)

Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients
by: Ali Zahit Bolaman, et al.
Published: (2021-01-01)

The protection of the myocardium by amifostine against mitoxantrone-induced acute cardiotoxicity in rats
by: Vefki Gürhan Kadıköylü, et al.
Published: (2010-06-01)

The protection of the myocardium by amifostine against mitoxantrone-induced acute cardiotoxicity in rats
by: Vefki Gürhan Kadıköylü, et al.
Published: (2010-06-01)

Evaluation of New Generation Sequencing (NGS)-Based Somatic Gene Variations and Real-Time Polymerase Chain Reaction (PCR)-Based Gene Fusions in Elderly and Young Acute Leukemia Patients: A Retrospective View
by: İbrahim Halil Erdoğdu, et al.
Published: (2024-01-01)

Plasmacytoid dendritic cell tumor: A case report
by: Füruzan Kacar Döger, et al.
Published: (2011-12-01)

Plasmacytoid dendritic cell tumor: A case report
by: Füruzan Kacar Döger, et al.
Published: (2011-12-01)

Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
by: Arzu Cengiz, et al.
Published: (2018-08-01)

Adrenal incidentaloma and the Janus Kinase 2 V617F mutation: A case-based review of the literature
by: Mustafa Unubol, et al.
Published: (2013-01-01)

RETRACTED: Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma
by: Ali Z. Bolaman, et al.
Published: (2021-09-01)

Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey
by: Ayşe Hilal Eroğlu Küçükdiler, et al.
Published: (2021-01-01)

PB1796: DETERMINATION OF THE RELATIONSHIP BETWEEN NEXT GENERATION SEQUENCING AND FLOW CYTOMETRY RESULTS IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA
by: I. Yavasoglu, et al.
Published: (2022-06-01)

Original Versus Generic Lenalidomide in Patients with Relapsed/ Refractory Multiple Myeloma: Comparison of Efficacy and Adverse Events
by: Ali Zahit Bolaman, et al.
Published: (2021-02-01)

Rosiglitazone reduces hepatic fat content
by: Buckingham, R, et al.
Published: (2000)

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
by: Kahn, SE, et al.
Published: (2006)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
by: Investigators, D
Published: (2011)

Guidance on rosiglitazone for type 2 diabetes mellitus.
by: Matthews, DR
Published: (2001)

Incidence of diabetes following ramipril or rosiglitazone withdrawal
by: Holman, R, et al.
Published: (2011)

Rosiglitazone-associated fractures in type 2 diabetes
by: Kahn, SE, et al.
Published: (2008)